2019 annual financial data
Recursion Pharmaceuticals 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,333.84%.
Operating income was -62,441,000 USD and net income was -62,525,000 USD.
Operating cash flow was -57,042,000 USD.
Get free Recursion Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,711,000 USD
- Operating income
- -62,441,000 USD
- Net income
- -62,525,000 USD
- Operating cash flow
- -57,042,000 USD